The landscape of addiction medicine and pharmacological support has evolved dramatically over recent decades, moving toward sustained-release formulations designed to improve patient adherence, reduce treatment burden, and support long-term recovery. Across the United States, Canada, Brazil, Mexico, Australia, New Zealand, the United Kingdom, the Netherlands, Germany, and Switzerland, healthcare providers continually seek advanced therapeutic interventions […]